Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia

Stopped Despite a recruitment target that was not met, we managed to achieve more than 50% of inclusions and 33% of deaths, enabling us to carry out an initial analysis of the primary endpoint

Conditions

• Relapsed or Refractory Acute Myeloid Leukemia

Interventions

• DRUG: Dexamethasone
• DRUG: Amsacrine
• DRUG: Cytarabine
• DRUG: Azacitidine

Sponsor

University Hospital, Toulouse